The Wellcome-HRB Clinical Research Facility is a clinical space located at the centre of the hospital dedicated to research involving patients since 2013. It is a partnership between TCD and St. James’s Hospital with a highly experienced multidisciplinary staff. Clinical research is critical to improving patient care. We work to encourage, support and educate clinical staff and promote a culture of research as part of everyday treatment planning.
The SJH-CRF exists to ensure research is accessible and performed to the highest standards. Patient safety is paramount and continuous learning is part of our ethos. We use HRB funding to support:
Clinical trials of new medicines to demonstrate they are effective and safe.
Clinical trials of new medical-devices and interventions that influence health
Studies where information and samples are collected from patients to better understand disease.
Over the next five years, we will expand the amount of high-quality clinical-research offered to patients and conduct more challenging studies and extend our support to the cancer trials unit. HRB funding will be used to complete 5 workpackages that will:
1. Optimise the conduct of clinical-trials by identifying barriers to successful performance and by collaborating with patients to improve participation.
2. Integrate our research pharmacy services to increase the range of trials offered to patients and make these more accessible.
3. Transform our ability to offer cutting-edge trials of advanced treatments for rare diseases including gene therapies.
4. Encourage new research by creating an environment which enables health professionals and scientists to perform trials which begin with a discovery they make or a problem they identify. 5. Collaborate to develop stronger links with Cancer and the National Children’s Hospital to improve research impact for patients.
We will create opportunities for important discoveries and improve access for patients to new treatments providing better health outcomes.
